High immunogenicity of delayed third dose of hepatitis B vaccine in travellers

Vaccine

Volumn 25, Issue 17, 2007, Pages 3482-3484

  Jackson, Yves ^a   Chappuis, François ^a   Mezger, Nathalie ^a   Kanappa, Kathi ^a   Loutan, Louis ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Delayed dose; Hepatitis B vaccine; Traveller

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B CORE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; TRAVEL; VACCINATION;

ADOLESCENT; ADULT; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TRAVEL;

EID: 34047131846     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.053     Document Type: Article

References (13)

1. Shouval D. Hepatitis B vaccines. J Hepatol 39 (2003) 70-76
2. European Consensus Group on Hepatits B Immunity. Are booster immunizations needed for lifelong hepatitis B immunity?. Lancet 355 (2000) 561-565
3. West D., and Calandra G. Vaccine induced immunologic memory for hepatitis B antigen: implication for policy on booster vaccination. Vaccine 14 (1996) 1019-1027
4. Wang R., Boland J., van Hattum J., and de Gast G. Long term persistance of T cell memory to HbsAg after hepatitis B vaccination. World J Gastroenterol 10 (2004) 260-263
5. Banatvala J., Van Damme P., and Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 19 (2001) 877-885
6. Bauer T., and Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 24 (2006) 572-577
7. Zanetti A., Mariano A., Romano l, D'Amelio R., Chironna M., Coppola R., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 (2005) 1379-1384
8. Midleman A., Kozinetz C., Robertson L., DuRant R., and Jean Emans S. The effect of late doses on the achievement of seroprotection and antibody titer levels with hepatitis B immunization among adolescents. Pediatrics 107 (2001) 1065-1069
9. Jilg W., Schmidt M., and Deinhardtf. Vaccination against hepatitis B: a comparison of three different vaccination schedules. J Inf Dis 160 (1989) 766-769
10. Wiström J., Ahlm C., Lundberg S., Settergren B., and Tärnvik A. Booster vaccination with recombinant hepatitis B vaccine 4 years after priming with one single dose. Vaccine 17 (1999) 2162-2165
11. Marsano L., West D., Chan I., Hesley T., Cox J., Kackworth V., et al. Vaccine 16 (1998) 624-629
12. Coates T., Wilson R., Patrick G., André F., and Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 23 3 (2001) 392-403
13. Fisman D.N., Agrawal D., and Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Inf Dis 35 (2002) 1368-1375